2024a. The burden of neurological conditions in north Africa and the Middle East, 1990–2019: a systematic analysis of the Global Burden of Disease Study 2019. Lancet Glob Health, 12, e960-e982.

2024b. Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Public Health, 9, e729-e744.

2024c. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet, 403, 2133–2161.

Alosi JA, McDonald DE, Schneider JS, Privette AR, McFadden DW. Pterostilbene inhibits breast cancer in vitro through mitochondrial depolarization and induction of caspase-dependent apoptosis. J Surg Res. 2010;161:195–201.

Article  CAS  PubMed  Google Scholar 

Asgharian P, Tazekand AP, Hosseini K, Forouhandeh H, Ghasemnejad T, Ranjbar M, Hasan M, Kumar M, Beirami SM, Tarhriz V. Potential mechanisms of quercetin in cancer prevention: focus on cellular and molecular targets. Cancer Cell Int. 2022;22:257.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Azzini E, Barnaba L, Mattera M, Calina D, Sharifi-Rad J, Cho WC. Updated evidence on raspberries as functional foods: anticancer bioactivity and therapeutic implications. Food Frontiers. 2024;5:2351–82.

Article  CAS  Google Scholar 

Basri DF, Lew LC, Muralitharan RV, Nagapan TS, Ghazali AR. Pterostilbene inhibits the melanogenesis activity in UVB-irradiated B164A5 cells. Dose-Response. 2021;19:15593258211047652.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Butt NA, Kumar A, Dhar S, Rimando AM, Akhtar I, Hancock JC, Lage JM, Pound CR, Lewin JR, Gomez CR. Targeting MTA 1/HIF-1α signaling by pterostilbene in combination with histone deacetylase inhibitor attenuates prostate cancer progression. Cancer Med. 2017;6:2673–85.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chakraborty A, Gupta N, Ghosh K, Roy P. In vitro evaluation of the cytotoxic, anti-proliferative and anti-oxidant properties of pterostilbene isolated from Pterocarpus marsupium. Toxicol In Vitro. 2010;24:1215–28.

Article  CAS  PubMed  Google Scholar 

Chang G, Xiao W, Xu Z, Yu D, Li B, Zhang Y, Sun X, Xie Y, Chang S, Gao L. Pterostilbene induces cell apoptosis and cell cycle arrest in T-cell leukemia/lymphoma by suppressing the ERK1/2 pathway. Biomed Res Int. 2017;2017:9872073.

Article  PubMed  PubMed Central  Google Scholar 

Chatterjee K, Alsharif D, Mazza C, Syar P. Resveratrol and pterostilbene exhibit anticancer properties involving the downregulation of HPV oncoprotein E6 in cervical cancer cells. Nutrients. 2018;10:243.

Article  PubMed  PubMed Central  Google Scholar 

Chen RJ, Ho CT, Wang YJ. Pterostilbene induces autophagy and apoptosis in sensitive and chemoresistant human bladder cancer cells. Mol Nutr Food Res. 2010;54:1819–32.

Article  CAS  PubMed  Google Scholar 

Chen RJ, Kuo HC, Cheng LH, Lee YH, Chang WT, Wang BJ, Wang YJ, Cheng HC. Apoptotic and nonapoptotic activities of pterostilbene against cancer. Int J Mol Sci. 2018;19:287.

Article  PubMed  PubMed Central  Google Scholar 

Chen LZ, Yao L, Jiao MM, Shi JB, Tan Y, Ruan BF, Liu XH. Novel resveratrol-based flavonol derivatives: synthesis and anti-inflammatory activity in vitro and in vivo. Eur J Med Chem. 2019;175:114–28.

Article  CAS  PubMed  Google Scholar 

Chiou YS, Tsai ML, Wang YJ, Cheng AC, Lai WM, Badmaev V, Ho CT, Pan MH. Pterostilbene inhibits colorectal aberrant crypt foci (ACF) and colon carcinogenesis via suppression of multiple signal transduction pathways in azoxymethane-treated mice. J Agric Food Chem. 2010;58:8833–41.

Article  CAS  PubMed  Google Scholar 

Chiou YS, Tsai ML, Nagabhushanam K, Wang YJ, Wu CH, Ho CT, Pan MH. Pterostilbene is more potent than resveratrol in preventing azoxymethane (AOM)-induced colon tumorigenesis via activation of the NF-E2-related factor 2 (Nrf2)-mediated antioxidant signaling pathway. J Agric Food Chem. 2011;59:2725–33.

Article  CAS  PubMed  Google Scholar 

2023. Dictionary of Natural Products on USB: CRC Press Boca Raton, Florida, USA.

Cunha ARD, Compton K, Xu R, Mishra R, Drangsholt MT, Antunes JLF, Kerr AR, Acheson AR, Lu D, Wallace LE, Kocarnik JM, Fu W, Dean FE, Pennini A, Henrikson HJ, Alam T, Ababneh E, Abd-Elsalam S, Abdoun M, Abidi H, Abubaker Ali H, Abu-Gharbieh E, Adane TD, Addo IY, Ahmad A, Ahmad S, Ahmed Rashid T, Akonde M, Al Hamad H, Alahdab F, Alimohamadi Y, Alipour V, Al-Maweri SA, Alsharif U, Ansari-Moghaddam A, Anwar SL, Anyasodor AE, Arabloo J, Aravkin AY, Aruleba RT, Asaad M, Ashraf T, Athari SS, Attia S, Azadnajafabad S, Azangou-Khyavy M, Badar M, Baghcheghi N, Banach M, Bardhan M, Barqawi HJ, Bashir NZ, Bashiri A, Benzian H, Bernabe E, Bhagat DS, Bhojaraja VS, Bjørge T, Bouaoud S, Braithwaite D, Briko NI, Calina D, Carreras G, Chakraborty PA, Chattu VK, Chaurasia A, Chen MX, Cho WCS, Chu DT, Chukwu IS, Chung E, Cruz-Martins N, Dadras O, Dai X, Dandona L, Dandona R, Daneshpajouhnejad P, Darvishi Cheshmeh R, Darwesh AM, Debela SA, Derbew Molla M, Dessalegn FN, Dianati-Nasab M, Digesa LE, Dixit SG, Dixit A, Djalalinia S, El Sayed I, El Tantawi M, Enyew DB, Erku DA, Ezzeddini R, Fagbamigbe AF, Falzone L, Fetensa G, Fukumoto T, Gaewkhiew P, Gallus S, Gebrehiwot M, Ghashghaee A, et al. The global, regional, and national burden of adult lip, oral, and pharyngeal cancer in 204 countries and territories: a systematic analysis for the global burden of disease study 2019. JAMA Oncol. 2023;9:1401–16.

Article  PubMed  PubMed Central  Google Scholar 

Daniel M, Tollefsbol TO. Pterostilbene down-regulates hTERT at physiological concentrations in breast cancer cells: potentially through the inhibition of cMyc. J Cell Biochem. 2018;119:3326–37.

Article  CAS  PubMed  Google Scholar 

Davodabadi F, Sajjadi SF, Sarhadi M, Mirghasemi S, Hezaveh MN, Khosravi S, Andani MK, Cordani M, Basiri M, Ghavami S. Cancer chemotherapy resistance: mechanisms and recent breakthrough in targeted drug delivery. Eur J Pharmacol. 2023;958:176013.

Article  CAS  PubMed  Google Scholar 

de Pinto G, Mignozzi S, la Vecchia C, Levi F, Negri E, Santucci C. Global trends in cutaneous malignant melanoma incidence and mortality. Melanoma Res. 2024;34:265–75.

Article  PubMed  PubMed Central  Google Scholar 

Dellinger TH, Wu X, Cho H, Yost SE, Ruel NH, Invernizzi M, Senguttuvan RN, Frankel PH, Kebria M, Han ES, Song M, Leon MD, Eng M, Tinsley R, Schmolze D, Chang S, Stella JA. Differential gene expression analysis of a phase II randomized clinical trial of patients with endometrial cancer (EC) treated with megestrol acetate ± pterostilbene. J Clin Oncol. 2024;42:e17601.

Article  Google Scholar 

Dyba T, Randi G, Bray F, Martos C, Giusti F, Nicholson N, Gavin A, Flego M, Neamtiu L, Dimitrova N. The European cancer burden in 2020: Incidence and mortality estimates for 40 countries and 25 major cancers. Eur J Cancer. 2021;157:308–47.

Article  PubMed  PubMed Central  Google Scholar 

Elsherbini AM, Sheweita SA, Sultan AS. Pterostilbene as a phytochemical compound induces signaling pathways involved in the apoptosis and death of mutant P53-breast cancer cell lines. Nutr Cancer. 2021;73:1976–84.

Article  CAS  PubMed  Google Scholar 

ENZO.COM. 2022. Pterostilbene. https://www.enzolifesciences.com/ALX-385-034/pterostilbene/ [Accessed].

Feng Y, Yang Y, Fan C, Di S, Hu W, Jiang S, Li T, Ma Z, Chao D, Feng X. Pterostilbene inhibits the growth of human esophageal cancer cells by regulating endoplasmic reticulum stress. Cell Physiol Biochem. 2016;38:1226–44.

Article  CAS  PubMed  Google Scholar 

Ferrer P, Asensi M, Segarra R, Ortega A, Benlloch M, Obrador E, Varea MT, Asensio G, Jordá L, Estrela JM. Association between pterostilbene and quercetin inhibits metastatic activity of B16 melanoma. Neoplasia. 2005;7:37–47.

Article  CAS  PubMed  PubMed Central  Google Scholar 

GBD. Global, regional, and national burden of colorectal cancer and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Gastroenterol Hepatol. 2022;7:627–47.

Article  Google Scholar 

Huang CS, Ho CT, Tu SH, Pan MH, Chuang CH, Chang HW, Chang CH, Wu CH, Ho YS. Long-term ethanol exposure-induced hepatocellular carcinoma cell migration and invasion through lysyl oxidase activation are attenuated by combined treatment with pterostilbene and curcumin analogues. J Agric Food Chem. 2013;61:4326–35.

Article  CAS  PubMed  Google Scholar 

Huang XY, Zhang SZ, Wang WX. Enhanced antitumor efficacy with combined administration of astragalus and pterostilbene for melanoma. Asian Pac J Cancer Prev. 2014;15:1163–9.

Article  PubMed  Google Scholar 

Hung CM, Liu LC, Ho CT, Lin YC, Way TD. Pterostilbene enhances TRAIL-induced apoptosis through the induction of death receptors and downregulation of cell survival proteins in TRAIL-resistance triple negative breast cancer cells. J Agric Food Chem. 2017;65:11179–91.

Article  CAS  PubMed  Google Scholar 

Hura N, Sawant AV, Kumari A, Guchhait SK, Panda D. Combretastatin-inspired heterocycles as antitubulin anticancer agents. ACS Omega. 2018;3:9754–69.

Article  CAS  PubMed